My Quote Request
No products added yet
6505-01-272-6053
20 Products
PAMELOR CAPSULES
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505012726053
NSN
6505-01-272-6053
PAMELOR CAPSULES
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505012726053
NSN
6505-01-272-6053
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS NORTRIPTYLINE HYDROCHLORIDE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORTRIPTYLINE HYDROCHLORIDE CAPSULES USP 25MG 500S BT
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PAMELOR BY SANDOZ PHARM DIV.
Related Searches:
NDC00078-0087-08
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505012726053
NSN
6505-01-272-6053
NDC00078-0087-08
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505012726053
NSN
6505-01-272-6053
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS NORTRIPTYLINE HYDROCHLORIDE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORTRIPTYLINE HYDROCHLORIDE CAPSULES USP 25MG 500S BT
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PAMELOR BY SANDOZ PHARM DIV.
Related Searches:
NDC45334-0300-04PHARM. SPECIALTI
OINTMENT BASE
NSN, MFG P/N
6505012726054
NSN
6505-01-272-6054
NDC45334-0300-04PHARM. SPECIALTI
OINTMENT BASE
NSN, MFG P/N
6505012726054
NSN
6505-01-272-6054
MFG
PHARMACEUTICAL SPECIALTIES INC
Description
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: NON-COMEDOGENIC; CONTAINS NO PARABENSOR LANOLIN,LUBRICANT/MOISTURIZER AND COMPOUNDING VEHICLE
Related Searches:
VANICREAM PHARM.SPECIALTIES, INC
OINTMENT BASE
NSN, MFG P/N
6505012726054
NSN
6505-01-272-6054
VANICREAM PHARM.SPECIALTIES, INC
OINTMENT BASE
NSN, MFG P/N
6505012726054
NSN
6505-01-272-6054
MFG
PHARMACEUTICAL SPECIALTIES INC
Description
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: NON-COMEDOGENIC; CONTAINS NO PARABENSOR LANOLIN,LUBRICANT/MOISTURIZER AND COMPOUNDING VEHICLE
Related Searches:
95-0770
HYDRALAZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012727036
NSN
6505-01-272-7036
95-0770
HYDRALAZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012727036
NSN
6505-01-272-7036
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS HYDRALAZINE HYDROCHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDRALAZINE HYDROCHLORIDE INJECTION USP 1ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SHELF LIFE IS 12 MONTHS
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00517-0901-25
HYDRALAZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012727036
NSN
6505-01-272-7036
NDC00517-0901-25
HYDRALAZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012727036
NSN
6505-01-272-7036
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS HYDRALAZINE HYDROCHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDRALAZINE HYDROCHLORIDE INJECTION USP 1ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SHELF LIFE IS 12 MONTHS
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC63323-0614-01
HYDRALAZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012727036
NSN
6505-01-272-7036
NDC63323-0614-01
HYDRALAZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012727036
NSN
6505-01-272-7036
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS HYDRALAZINE HYDROCHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDRALAZINE HYDROCHLORIDE INJECTION USP 1ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SHELF LIFE IS 12 MONTHS
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
CIPRO
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012729378
NSN
6505-01-272-9378
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN TABLETS USP 750MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: UNIT DOSE; 100 TABLETS
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
CIPRO TABLETS
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012729378
NSN
6505-01-272-9378
CIPRO TABLETS
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012729378
NSN
6505-01-272-9378
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN TABLETS USP 750MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: UNIT DOSE; 100 TABLETS
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00026-8514-48
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012729378
NSN
6505-01-272-9378
NDC00026-8514-48
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012729378
NSN
6505-01-272-9378
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN TABLETS USP 750MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: UNIT DOSE; 100 TABLETS
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
7LURIDE TABLETS
SODIUM FLUORIDE TABLETS,USP
NSN, MFG P/N
6505012729387
NSN
6505-01-272-9387
7LURIDE TABLETS
SODIUM FLUORIDE TABLETS,USP
NSN, MFG P/N
6505012729387
NSN
6505-01-272-9387
MFG
PRC INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS SODIUM FLUORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM FLUORIDE TABLETS USP GRAPE FLAVORED 120S BT
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: GRAPE FLAVORED TABLETS; CHEWABLE
Related Searches:
LURIDE LOZI TABLETS
SODIUM FLUORIDE TABLETS,USP
NSN, MFG P/N
6505012729387
NSN
6505-01-272-9387
LURIDE LOZI TABLETS
SODIUM FLUORIDE TABLETS,USP
NSN, MFG P/N
6505012729387
NSN
6505-01-272-9387
MFG
COLGATE ORAL PHARMACEUTICALS INC. DBA COLGATE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS SODIUM FLUORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM FLUORIDE TABLETS USP GRAPE FLAVORED 120S BT
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: GRAPE FLAVORED TABLETS; CHEWABLE
Related Searches:
NDC00126-0014-21
SODIUM FLUORIDE TABLETS,USP
NSN, MFG P/N
6505012729387
NSN
6505-01-272-9387
NDC00126-0014-21
SODIUM FLUORIDE TABLETS,USP
NSN, MFG P/N
6505012729387
NSN
6505-01-272-9387
MFG
COLGATE ORAL PHARMACEUTICALS INC. DBA COLGATE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS SODIUM FLUORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM FLUORIDE TABLETS USP GRAPE FLAVORED 120S BT
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: GRAPE FLAVORED TABLETS; CHEWABLE
Related Searches:
NDC00070-2343-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
NDC00070-2343-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
MFG
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
NDC00075-0200-62
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
NDC00075-0200-62
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
NDC00258-3634-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
NDC00258-3634-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
MFG
FOREST PHARMACEUTICALS INC SUB OF FOREST LABORATORIES INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
NDC00603-5951-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
NDC00603-5951-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
SLO-BID GYROCAPS
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
SLO-BID GYROCAPS
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012729388
NSN
6505-01-272-9388
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
NDC49281-0912-12
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012729391
NSN
6505-01-272-9391
NDC49281-0912-12
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012729391
NSN
6505-01-272-9391
MFG
SANOFI PASTEUR INC.
Description
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: DILUENT FOR 20-DOSE YELLOW FEVER VACCINE
Related Searches:
NDC00093-0840-15
KETOCONAZOLE CREAM
NSN, MFG P/N
6505012729401
NSN
6505-01-272-9401
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE INGREDIENT AND STRENGTH: 2.000 KETOCONAZOLE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOCONAZOLE CREAM 2% 15GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
